Jan Schulze

5.1k total citations · 1 hit paper
69 papers, 2.3k citations indexed

About

Jan Schulze is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Jan Schulze has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Jan Schulze's work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Management and Education (11 papers) and Metabolism, Diabetes, and Cancer (11 papers). Jan Schulze is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Management and Education (11 papers) and Metabolism, Diabetes, and Cancer (11 papers). Jan Schulze collaborates with scholars based in Germany, United States and United Kingdom. Jan Schulze's co-authors include M Hanefeld, Ulrich Julius, H Schmechel, Uta Schwanebeck, Sven Fischer, H J Ziegelasch, Joachim Lindner, Sabine Fischer, Stefan R. Bornstein and Peter E. H. Schwarz and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Jan Schulze

65 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1996 708 citations M Hanefeld, Sven Fischer et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Schulze Germany	20	1.4k	591	428	374	324	69	2.3k
Aramesh Saremi United States	16	892 0.7×	327 0.6×	279 0.7×	134 0.4×	562 1.7×	38	1.9k
Cristina Bianchi Italy	23	819 0.6×	378 0.6×	441 1.0×	164 0.4×	201 0.6×	96	1.7k
Huimin Zhang China	28	678 0.5×	611 1.0×	341 0.8×	543 1.5×	78 0.2×	89	3.1k
Roger Lehmann Switzerland	26	1.5k 1.1×	752 1.3×	1.7k 4.0×	972 2.6×	310 1.0×	90	3.2k
Takao MIYATA Japan	4	1.8k 1.3×	418 0.7×	338 0.8×	219 0.6×	252 0.8×	8	2.4k
Moonsuk Nam South Korea	23	510 0.4×	452 0.8×	193 0.5×	212 0.6×	328 1.0×	71	1.4k
Imran Ali Khan Saudi Arabia	20	289 0.2×	344 0.6×	381 0.9×	216 0.6×	179 0.6×	130	1.5k
Dana E. Wilson United States	23	643 0.5×	373 0.6×	510 1.2×	114 0.3×	218 0.7×	45	1.6k
Esther Granot Israel	23	588 0.4×	388 0.7×	863 2.0×	110 0.3×	330 1.0×	99	2.0k
Hiroki Endo Japan	27	414 0.3×	817 1.4×	921 2.2×	76 0.2×	629 1.9×	115	2.6k

Countries citing papers authored by Jan Schulze

Since Specialization

Citations

This map shows the geographic impact of Jan Schulze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Schulze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Schulze more than expected).

Fields of papers citing papers by Jan Schulze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Schulze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Schulze. The network helps show where Jan Schulze may publish in the future.

Co-authorship network of co-authors of Jan Schulze

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Schulze. A scholar is included among the top collaborators of Jan Schulze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Schulze. Jan Schulze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schulze, Jan, Anne Herrmann, Harish Poptani, et al.. (2025). Methodology for generating chorioallantoic membrane patient-derived xenograft (CAM-PDX) models of pleural mesothelioma and performing preclinical imaging for the translation of cancer studies and drug screening.. F1000Research. 14. 481–481.

Preis, Eduard, Konrad Engelhardt, Muhammad Amin, et al.. (2024). In vitro and in ovo photodynamic efficacy of nebulized curcumin-loaded tetraether lipid liposomes prepared by DC as stable drug delivery system. European Journal of Pharmaceutical Sciences. 196. 106748–106748. 5 indexed citations

Schulze, Jan, Muhammad Umair Amin, Konrad Engelhardt, et al.. (2023). Photoactive Parietin-loaded nanocarriers as an efficient therapeutic platform against triple-negative breast cancer. International Journal of Pharmaceutics. 643. 123217–123217. 5 indexed citations

Nawabi, Jawed, et al.. (2022). Cerebrovascular Events in Suspected Sepsis: Retrospective Prevalence Study in Critically Ill Patients Undergoing Full-Body Computed Tomography. Frontiers in Neurology. 13. 811022–811022. 1 indexed citations

Preis, Eduard, et al.. (2021). The chorioallantoic membrane as a bio-barrier model for the evaluation of nanoscale drug delivery systems for tumour therapy. Advanced Drug Delivery Reviews. 174. 317–336. 26 indexed citations

Schulze, Jan, et al.. (2016). Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles. Acta Biomaterialia. 45. 210–222. 30 indexed citations

Schardt, K, et al.. (2013). 55-jähriger Patient mit abdominellen Schmerzen und Fieber. Der Internist. 54(10). 1256–1261. 1 indexed citations

Bergmann, Antje, et al.. (2007). Genetic Variation of Neurogenin 3 is Slightly Associated with Hyperproinsulinaemia and Progression Toward Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 116(3). 178–183. 4 indexed citations

Hoffmann, Karl‐Titus, Manuel Mattheisen, Stefan Dahm, et al.. (2007). A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia. 50(7). 1418–1422. 24 indexed citations

10.

Bergmann, Antje, et al.. (2007). A Simplified Finnish Diabetes Risk Score to Predict Type 2 Diabetes Risk and Disease Evolution in a German Population. Hormone and Metabolic Research. 39(9). 677–682. 84 indexed citations

11.

Coll‐Planas, Laura, Antje Bergmann, Peter Schwarz, Francisco Guillén‐Grima, & Jan Schulze. (2007). Vergleich der Versorgungsqualität älterer Diabetiker durch ambulante Pflegedienste im häuslichen Bereich mit der im stationären Bereich in Pflegeheimen in Dresden. PubMed. 101(9). 623–629. 15 indexed citations

12.

Schwarz, Peter E. H., et al.. (2007). Development of a Diabetes Prevention Management Program for Clinical Practice. Public Health Reports. 122(2). 258–263. 56 indexed citations

13.

Schwarz, Peter E. H., Jan Schwarz, Stefan R. Bornstein, & Jan Schulze. (2006). Diabetes Prevention - From Physiology to Implementation. Hormone and Metabolic Research. 38(7). 460–464. 17 indexed citations

14.

Pfützner, Andreas, Eberhard Standl, Jan Schulze, et al.. (2006). Association of high-sensitive C-reactive protein with advanced stage β-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clinical Chemistry and Laboratory Medicine (CCLM). 44(5). 556–60. 23 indexed citations

15.

Hauner, Hans, et al.. (2005). Prevention of type 2 diabetes mellitus. DMW - Deutsche Medizinische Wochenschrift. 130(17). 1053–1054. 17 indexed citations

16.

Naumann, Ralph, Bettina Beuthien‐Baumann, Jan Schulze, et al.. (2004). Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. British Journal of Cancer. 90(3). 620–625. 106 indexed citations

17.

Schulze, Jan, et al.. (2003). Verbesserung der Versorgungvon Diabetikern durch das sächsische Betreuungsmodell. DMW - Deutsche Medizinische Wochenschrift. 128(21). 1161–1166. 12 indexed citations

18.

Kumar, Sudhesh, et al.. (1998). Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly Type 2 diabetic patients. Diabetic Medicine. 15(9). 772–779. 33 indexed citations

19.

Lindner, Tom H., Claudia Gragnoli, Hiroto Furuta, et al.. (1997). Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene.. Journal of Clinical Investigation. 100(6). 1400–1405. 57 indexed citations

20.

Hanefeld, M, Sven Fischer, Ulrich Julius, et al.. (1996). Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 39(12). 1577–1583. 708 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact